[go: up one dir, main page]

AU3830895A - Dimeric il-4 inhibitors - Google Patents

Dimeric il-4 inhibitors

Info

Publication number
AU3830895A
AU3830895A AU38308/95A AU3830895A AU3830895A AU 3830895 A AU3830895 A AU 3830895A AU 38308/95 A AU38308/95 A AU 38308/95A AU 3830895 A AU3830895 A AU 3830895A AU 3830895 A AU3830895 A AU 3830895A
Authority
AU
Australia
Prior art keywords
dimeric
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38308/95A
Inventor
George M Cox
Rebecca W. Vanderslice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Boulder Inc
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Publication of AU3830895A publication Critical patent/AU3830895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU38308/95A 1994-10-07 1995-10-05 Dimeric il-4 inhibitors Abandoned AU3830895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US319496 1981-11-09
US31949694A 1994-10-07 1994-10-07
PCT/US1995/013101 WO1996011213A1 (en) 1994-10-07 1995-10-05 Dimeric il-4 inhibitors

Publications (1)

Publication Number Publication Date
AU3830895A true AU3830895A (en) 1996-05-02

Family

ID=23242482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38308/95A Abandoned AU3830895A (en) 1994-10-07 1995-10-05 Dimeric il-4 inhibitors

Country Status (2)

Country Link
AU (1) AU3830895A (en)
WO (1) WO1996011213A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
ES2334408T3 (en) * 1995-10-23 2010-03-09 Zenyth Operations Pty Ltd HEMATOPOYETINE RECEIVER AND GENETIC SEQUENCES THAT CODE IT.
US6548644B1 (en) * 1997-03-10 2003-04-15 Immunex Corporation Site protected protein modification
US6451986B1 (en) 1998-06-22 2002-09-17 Immunex Corporation Site specific protein modification
EP0982317A1 (en) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalent inhibitors of the proteasome
EP0995757A3 (en) * 1998-08-26 2002-05-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalent inhibitors of the proteasome
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US7083949B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
ES2614260T3 (en) 2000-05-26 2017-05-30 Immunex Corporation Use of antibodies against the interleukin-4 receptor and compositions thereof
EP1491554A1 (en) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGylated soluble gp130-dimers useful as a medicament
US10906957B2 (en) 2016-09-27 2021-02-02 Epicentrx, Inc. Immunomodulatory fusion proteins
WO2019067770A1 (en) 2017-09-27 2019-04-04 Epicentrx, Inc. Immunomodulatory fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003555A1 (en) * 1989-09-07 1991-03-21 Schering Corporation Interleukin-4 receptors
DE69233069T2 (en) * 1991-03-15 2003-11-27 Amgen Inc., Thousand Oaks PEGYLATION OF POLYPEPTIDES
WO1993011234A1 (en) * 1991-11-27 1993-06-10 Schering Corporation Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4
DE4228839A1 (en) * 1992-08-29 1994-03-03 Behringwerke Ag Methods for the detection and determination of mediators

Also Published As

Publication number Publication date
WO1996011213A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
DE69533256D1 (en) Chimäre komplement inhibitor proteine
EP0818448B8 (en) Cycloalkano-pyridine as CETP inhibitors
AU4269896A (en) Fibronectin adhesion inhibitors
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
AU3832895A (en) Thrombin inhibitors
AU4231197A (en) Hppd gene and inhibitors
EP0687060A3 (en) Power amplifier
AU6477498A (en) Scale inhibitors
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
EP0690494A3 (en) Connection and build-up-process for multi-chip-modules
AU3877095A (en) Modified proteinase inhibitors
AU692123B2 (en) 5alpha-reductase inhibitors
AU3830895A (en) Dimeric il-4 inhibitors
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
GB9425701D0 (en) Enzyme inhibitors
AU1753495A (en) Pushing unit
HU9503783D0 (en) Squvalen syntetase inhibitors
AU3559195A (en) Case for personal use
AU3994095A (en) Thrombocytotic factor
AU1013997A (en) Amylase inhibitors
AU4117396A (en) Morpholinoethylamide derivatives
AU6049796A (en) Lysyloxidase inhibitors
AU689566B2 (en) DC-89 derivatives
AU2051295A (en) Sterilizer apparatus
AU2812195A (en) Inhibitor